Cooper University Hospital is a teaching hospital and biomedical research facility located in Camden, New Jersey. The hospital formerly served as a clinical campus of Robert Wood Johnson Medical School and the University of Medicine and Dentistry of New Jersey.

There are 635 beds in Cooper Hospital University Medical Center.

During the past decade, Cooper Hospital University Medical Center conducted 140 clinical trials. In the 10-year time frame, 140 clinical trials started and 212 clinical trials were completed, i.e. on average, 151.4% percent of trials that started reached the finish line to date. In the past 5 years, 73 clinical trials started and 84 clinical trials were completed. i.e. 115.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cooper Hospital University Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 115 trials, followed by "Gynecologic Oncology Group" with 65 trials sponsored, "Alliance for Clinical Trials in Oncology" with 41 trials sponsored, "The Cooper Health System" with 30 trials sponsored and "Radiation Therapy Oncology Group" with 30 trials sponsored. Other sponsors include 241 different institutions and companies that sponsored additional 143 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cooper Hospital University Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 179 trials as a collaborator, "NRG Oncology" with 46 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 12 trials as a collaborator, "The Cooper Health System" with 11 trials as a collaborator and "Cancer and Leukemia Group B" with 10 trials as a collaborator. Other collaborators include 260 different institutions and companies that were collaborators in the rest 170 trials.

According to Clinical.Site data, the most researched conditions in "Cooper Hospital University Medical Center" are "Ovarian Cancer" (22 trials), "Primary Peritoneal Cavity Cancer" (18 trials), "Endometrial Cancer" (15 trials), "Cervical Cancer" (14 trials) and "Lung Cancer" (14 trials). Many other conditions were trialed in "Cooper Hospital University Medical Center" in a lesser frequency.

Most popular intervention types in "Cooper Hospital University Medical Center" are "Drug" (343 trials), "Other" (167 trials), "Biological" (99 trials), "Device" (81 trials) and "Procedure" (68 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (91 trials), "Quality-of-Life Assessment" (47 trials), "Paclitaxel" (42 trials), "Placebo" (35 trials) and "cisplatin" (34 trials). Other intervention names were less common.

The vast majority of trials in "Cooper Hospital University Medical Center" are 342 trials for "All" genders, 155 trials for "Female" genders and 21 trials for "Male" genders.

Currently, there are NaN active trials in "Cooper Hospital University Medical Center". undefined are not yet recruiting, 64 are recruiting, 90 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 279 completed trials in Cooper Hospital University Medical Center, 2 suspended trials, and 59 terminated clinical trials to date.

Out of the total trials that were conducted in Cooper Hospital University Medical Center, 27 "Phase 1" clinical trials were conducted, 180 "Phase 2" clinical trials and 176 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 17 trials, and there were also 88 trials that are defined as “Not Applicable".

Cooper Hospital University Medical Center has several departments that took part in Clinical trials: "MD Anderson Cancer Center at Cooper-Voorhees" - 106 trials, "Cooper University Neurological Institute" - 2 trials